Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
While CRISPR-Cas9 enables precise targeting of cancer-driving genetic aberrations, its clinical application is impeded by instability, delivery inefficiencies, and immunogenicity. Nanotechnology addresses these challenges by engineering nanocarriers that facilitate enhanced cellular uptake, promote...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2026-03-01
|
| Sarja: | Journal of Nanotheranostics |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2624-845X/7/1/6 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|